What is the address of Société Médicale VEKEMANS?

The registered office of Société Médicale VEKEMANS is located at Ortolanenlaan 58, 1170 Watermaal-Bosvoorde.

Is Société Médicale VEKEMANS still active?

Yes. According to the CBE (18 September 2026) Société Médicale VEKEMANS is active, legal situation “Normale toestand”, started on 1 October 2018.

Is Société Médicale VEKEMANS registered on Peppol?

No, Société Médicale VEKEMANS is currently not registered on the Peppol network.

What is the enterprise number of Société Médicale VEKEMANS?

The enterprise number of Société Médicale VEKEMANS is BE0707600548.

When was Société Médicale VEKEMANS founded?

Société Médicale VEKEMANS was founded on 1 October 2018.

Who are the directors of Société Médicale VEKEMANS?

According to the 2025 annual accounts, the directors of Société Médicale VEKEMANS are: Marc Vekemans.

Is Société Médicale VEKEMANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 2018; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Société Médicale VEKEMANS make in 2025?

Société Médicale VEKEMANS posted a profit after taxes of € 28,667 in financial year 2025.

What is the revenue of Société Médicale VEKEMANS?

As a small company, Société Médicale VEKEMANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 49,430.

Société Médicale VEKEMANS (Private Limited)

Dossier Société Médicale VEKEMANS, printed on 18 September 2026 from databakkes.be/en/0707600548/societe-medicale-vekemans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Société Médicale VEKEMANS from Watermaal-Bosvoorde, company number BE0707600548, closed financial year 2025 with a result of € 28,667 after tax. For that financial year Société Médicale VEKEMANS recorded a gross margin of € 49,430 and equity of € 18,700. Compared with financial year 2024, the result moved from € 31,530 to € 28,667. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 18,700

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,667

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 94,434

▲ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 28,667 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 35,777

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,674

▼ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 44,313 Gross margin 2022: € 44,313 First fiscal year in the series	€ 63,055 Gross margin 2023: € 63,055 ▲ 42% vs 2022 (€ 44,313) Favourable step	€ 48,354 Gross margin 2024: € 48,354 ▼ 23% vs 2023 (€ 63,055) Unfavourable step	€ 49,430 Gross margin 2025: € 49,430 ▲ 2% vs 2024 (€ 48,354) Favourable step	▲ 2%
Profit after taxes	€ 32,155 Profit after taxes 2022: € 32,155 First fiscal year in the series	€ 48,281 Profit after taxes 2023: € 48,281 ▲ 50% vs 2022 (€ 32,155) Favourable step	€ 31,530 Profit after taxes 2024: € 31,530 ▼ 35% vs 2023 (€ 48,281) Unfavourable step	€ 28,667 Profit after taxes 2025: € 28,667 ▼ 9% vs 2024 (€ 31,530) Unfavourable step	▼ 9%
Equity	€ 20,570 Equity 2022: € 20,570 First fiscal year in the series	€ 68,851 Equity 2023: € 68,851 ▲ 235% vs 2022 (€ 20,570) Favourable step	€ 18,700 Equity 2024: € 18,700 ▼ 73% vs 2023 (€ 68,851) Unfavourable step	€ 18,700 Equity 2025: € 18,700 Unchanged (€ 18,700) Unchanged
Total debts	€ 234,117 Total debts 2022: € 234,117 First fiscal year in the series	€ 67,561 Total debts 2023: € 67,561 ▼ 71% vs 2022 (€ 234,117) Favourable step	€ 124,816 Total debts 2024: € 124,816 ▲ 85% vs 2023 (€ 67,561) Unfavourable step	€ 117,495 Total debts 2025: € 117,495 ▼ 6% vs 2024 (€ 124,816) Favourable step	▼ 6%
Cash	€ 238,869 Cash 2022: € 238,869 First fiscal year in the series	€ 134,363 Cash 2023: € 134,363 ▼ 44% vs 2022 (€ 238,869) Unfavourable step	€ 90,737 Cash 2024: € 90,737 ▼ 32% vs 2023 (€ 134,363) Unfavourable step	€ 94,434 Cash 2025: € 94,434 ▲ 4% vs 2024 (€ 90,737) Favourable step	▲ 4%
Retained profit	€ 1,870 Retained profit 2022: € 1,870 First fiscal year in the series	€ 50,151 Retained profit 2023: € 50,151 ▲ € 48,281 vs 2022 (€ 1,870) Favourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 50,151) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 228,005 Dividend 2022: € 228,005 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 228,005) Unchanged	€ 81,681 Dividend 2024: € 81,681 Unchanged (€ 0) Unchanged	€ 28,667 Dividend 2025: € 28,667 ▼ 65% vs 2024 (€ 81,681) Unchanged	▼ 65%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 130 Bank debt 2024: € 130 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 130) Favourable step	▼ 100%
Balance sheet total	€ 254,687 Balance sheet total 2022: € 254,687 First fiscal year in the series	€ 136,413 Balance sheet total 2023: € 136,413 ▼ 46% vs 2022 (€ 254,687) Unchanged	€ 143,516 Balance sheet total 2024: € 143,516 ▲ 5% vs 2023 (€ 136,413) Unchanged	€ 136,195 Balance sheet total 2025: € 136,195 ▼ 5% vs 2024 (€ 143,516) Unchanged	▼ 5%

Key figures of Société Médicale VEKEMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Société Médicale VEKEMANS?

What happened at Société Médicale VEKEMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 28,667 (▼ 9% vs 2024). Source: NBB ↗
Oct 1, 2018 New establishment in Watermaal-Bosvoorde. KBO
2018 Marc Vekemans became a director. NBB
Oct 1, 2018 Start of the company according to the CBE. KBO

In short

From € 32,155 profit in 2022 to € 28,667 profit in 2025.

Paid € 37,803 in corporate taxes since 2022.

Best year ever: 2023, with € 48,281 profit.

Paid out € 338,353 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Société Médicale VEKEMANS? We notify you, reason included.

Follow Société Médicale VEKEMANS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marc Vekemans

Société Médicale VEKEMANS

Behind Société Médicale VEKEMANS is Marc Vekemans.

See the full network in the app

Directors

According to the 2025 annual accounts

Marc Vekemans

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Ortolanenlaan 58

1170 Watermaal-Bosvoorde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0707.600.548
VAT number: BE 0707.600.548
Registered office: Ortolanenlaan 58, 1170 Watermaal-Bosvoorde
Names & denominations: Société Médicale VEKEMANS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 October 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗